VANNUCCHI, ALESSANDRO MARIA

VANNUCCHI, ALESSANDRO MARIA  

Medicina Sperimentale e Clinica  

Mostra records
Risultati 1 - 20 di 567 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances 2016 Barbui, T; Thiele, J.; Gisslinger, H.; Finazzi, G.; Vannucchi, A.M.; Tefferi, A.
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion 2018 Barbui, Tiziano; Thiele, Jürgen; Gisslinger, Heinz; Kvasnicka, Hans Michael; Vannucchi, Alessandro M; Guglielmelli, Paola; Orazi, Attilio; Tefferi, Ayalew
A common megakaryocytic and erythrocytic precursor in murine erythroleukemia (Friend) cells? 1994 A. VANNUCCHI; PAOLETTI F.; GROSSI A.
A dot assay for the erythropoietin receptor using human recombinant 125I-erythropoietin. 1989 A. M. Vannucchi; A. Grossi; D. Rafanelli; L. Vannucchi; P. R. Ferrini
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera. 2014 F. Lussana;A. Carobbio;M. L. Randi;C. Elena;E. Rumi;G. Finazzi;I. Bertozzi;L. Pieri;M. Ruggeri;F. Palandri;N. Polverelli;E. Elli;A. Tieghi;A. Iurlo;M. Ruella;M. Cazzola;A. Rambaldi;A. M. Vannucchi;T. Barbui
A new prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. 2009 Francisco Cervantes; Brigitte Dupriez; Arturo Pereira; Francesco Passamonti; John T Reilly; Enrica Morra; Alessandro M Vannucchi; Ruben A Mesa; Jean-Loup Demory; Giovanni Barosi; Elisa Rumi; Ayalew Tefferi
A pathobiological pathway linking thrombopoietin, GATA1 and TGFbeta1 in the development of myelofibrosis 2005 VANNUCCHI AM.; BIANCHI L.; F. PAOLETTI; PANCRAZZI A.; TORRE E.; NISHIKAWA M.; ZINGARIELLO M.; DI BALDASSARRE A.; RANA RA.; LORENZINI R.; ALFANI E.; MIGLIACCIO G.; MIGLIACCIO AR.
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. 2013 Finazzi G;Vannucchi AM;Martinelli V;Ruggeri M;Nobile F;Specchia G;Pogliani EM;Olimpieri OM;Fioritoni G;Musolino C;Cilloni D;Sivera P;Barosi G;Finazzi MC;Di Tollo S;Demuth T;Barbui T;Rambaldi A
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment. 2012 Passamonti F;Thiele J;Girodon F;Rumi E;Carobbio A;Gisslinger H;Kvasnicka HM;Ruggeri M;Randi ML;Gangat N;Vannucchi AM;Gianatti A;Gisslinger B;Müllauer L;Rodeghiero F;d'Amore ES;Bertozzi I;Hanson CA;Boveri E;Marino F;Maffioli M;Caramazza D;Antonioli E;Carrai V;Buxhofer-Ausch V;Pascutto C;Cazzola M;Barbui T;Tefferi A
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. 1998 Rossi Ferrini P; Grossi A; Vannucchi AM; Barosi G; Guarnone R; Piva N; Musto P; Balleari E
A sensitive detection method for MPLW515L or MPLW515K mutation in chronic myeloproliferative disorders with locked nucleic acid-modified probes and real-time polymerase chain reaction. 2008 Alessandro Pancrazzi; Paola Guglielmelli; Vanessa Ponziani; Gaetano Bergamaschi; Alberto Bosi; Giovanni Barosi; Alessandro M Vannucchi
A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromes. 2009 Intermesoli T; Delaini F; Acerboni S; Salmoiraghi S; Spinelli O; Guerini V; Vannucchi AM; Mappa S; Rossi G; Rossi V; Di Bona E; Paratore S; Carobbio A; Rambaldi A; Barbui T; Bassan R.
A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process. 2010 Barosi G; Birgegard G; Finazzi G; Griesshammer M; Harrison C; Hasselbalch H; Kiladijan JJ; Lengfelder E; Mesa R; Mc Mullin MF; Passamonti F; Reilly JT; Vannucchi AM; Barbui T.
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations. 2014 Pennucci V;Zini R;Norfo R;Guglielmelli P;Bianchi E;Salati S;Sacchi G;Prudente Z;Tenedini E;Ruberti S;Paoli C;Fanelli T;Mannarelli C;Tagliafico E;Ferrari S;Vannucchi AM;Manfredini R.
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations. 2015 Pennucci, V1; Zini, R; Norfo, R; Guglielmelli, Paola; Bianchi, E; Salati, S; Sacchi, G; Prudente, Z; Tenedini, E; Ruberti, S; Paoli, C; Fanelli, Tiziana; Mannarelli, C; Tagliafico, E; Ferrari, S; Vannucchi, Am; Manfredini, R; Bogani, C; Bosi, Alberto; Fanelli, T; Fjerza, Rajmonda; Guglielmelli, P.
Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis. 2005 A. M. Vannucchi;A. Pancrazzi;P. Guglielmelli;S. D. Lollo;C. Bogani;G. Baroni;L. Bianchi;A. R. Migliaccio;A. Bosi;F. Paoletti
Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their Gata-1 expressione (GATA-1low mice). 2001 A. VANNUCCHI; L. BIANCHI; C. CELLAI; F. PAOLETTI; V. CARRAI; A. CALZOLARI; L. CENTURIONE; R. LORENZINI; C. CARTA; E. ALFANI; M. SANCHEZ; G. MIGLIACCIO; A. MIGLIACCIO
Acetylcholinesterase in murine erythroleukemia (Friend) cells: evidence for megakaryocyte-like expression and potential growt-regulatory role of enzyme activity 1992 F. PAOLETTI; MOCALI A.; VANNUCCHI A.M.
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms. 2013 Rumi E;Pietra D;Guglielmelli P;Bordoni R;Casetti I;Milanesi C;Sant'Antonio E;Ferretti V;Pancrazzi A;Rotunno G;Severgnini M;Pietrelli A;Astori C;Fugazza E;Pascutto C;Boveri E;Passamonti F;De Bellis G;Vannucchi A;Cazzola M.
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs 2021 Balliu M.; Calabresi L.; Bartalucci N.; Romagnoli S.; Maggi L.; Manfredini R.; Lulli M.; Guglielmelli P.; Vannucchi A.M.